10’s all round for FRAIL-M trial!

The MRDR-based FRAIL-M trial recently reached 10 participating sites with Concord Hospital in New South Wales, and Sunshine Coast University Hospital in Queensland opened in December.

Despite a difficult 2020 with COVID-19, the trial now has 10 patients recruited and counting!

FRAIL-M is a stratified randomised controlled trial to identify which competing treatment options (including current standard treatments) are more appropriate in transplant-ineligible myeloma patients according to frailty status.

Thanks to participating patients and sites for your support - we're looking towards a positive 2021.